J. Bartek and J. Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer, Cancer Cell, vol.3, issue.5, pp.421-429, 2003.
DOI : 10.1016/S1535-6108(03)00110-7

T. Su, Cellular Responses to DNA Damage: One Signal, Multiple Choices, Annual Review of Genetics, vol.40, issue.1, pp.187-208, 2006.
DOI : 10.1146/annurev.genet.40.110405.090428

H. Rajagopalan and C. Lengauer, Aneuploidy and cancer, Nature, vol.101, issue.7015, pp.338-341, 2004.
DOI : 10.1038/nature03099

K. Vousden and X. Lu, Live or let die: the cell's response to p53, Nature Reviews Cancer, vol.2, issue.8, pp.594-604, 2002.
DOI : 10.1038/nrc864

N. Mailand, J. Falck, C. Lukas, R. Syljuasen, M. Welcker et al., Rapid Destruction of Human Cdc25A in Response to DNA Damage, Science, vol.288, issue.5470, pp.1425-1429, 2000.
DOI : 10.1126/science.288.5470.1425

C. Peng, P. Graves, R. Thoma, Z. Wu, and A. Shaw, Mitotic and G2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216, Science, vol.277, issue.5331, pp.1501-1505, 1997.
DOI : 10.1126/science.277.5331.1501

Y. Sanchez, C. Wong, R. Thoma, R. Richman, Z. Wu et al., Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25, Science, vol.277, issue.5331, pp.1497-1501, 1997.
DOI : 10.1126/science.277.5331.1497

G. Fang, H. Yu, and M. Kirschner, The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase??initiation, Genes & Development, vol.12, issue.12, pp.1871-1883, 1998.
DOI : 10.1101/gad.12.12.1871

H. Zhou, J. Kuang, L. Zhong, W. Kuo, J. Gray et al., Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation, Nature Genetics, vol.20, issue.2, pp.189-193, 1998.
DOI : 10.1038/2496

R. Giet, C. Petretti, and C. Prigent, Aurora kinases, aneuploidy and cancer, a coincidence or a real link?, Trends in Cell Biology, vol.15, issue.5, pp.241-250, 2005.
DOI : 10.1016/j.tcb.2005.03.004
URL : https://hal.archives-ouvertes.fr/inserm-00966568

P. Meraldi, R. Honda, and E. Nigg, Aurora kinases link chromosome segregation and cell division to cancer susceptibility, Current Opinion in Genetics & Development, vol.14, issue.1, pp.29-36, 2004.
DOI : 10.1016/j.gde.2003.11.006

P. Meraldi, R. Honda, and E. Nigg, Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells, The EMBO Journal, vol.21, issue.4, pp.483-492, 2002.
DOI : 10.1093/emboj/21.4.483

A. Krystyniak, C. Garcia-echeverria, C. Prigent, and S. Ferrari, Inhibition of Aurora A in response to DNA damage, Oncogene, vol.20, pp.338-348, 2006.
DOI : 10.1038/sj.onc.1209056
URL : https://hal.archives-ouvertes.fr/inserm-00966637

Y. Pommier, C. Redon, V. Rao, J. Seiler, O. Sordet et al., Repair of and checkpoint response to topoisomerase I-mediated DNA damage, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.532, issue.1-2, pp.173-203, 2003.
DOI : 10.1016/j.mrfmmm.2003.08.016

F. Bienvenu, B. Barre, S. Giraud, S. Avril, and O. Coqueret, Transcriptional Regulation by a DNA-associated Form of Cyclin D1, Molecular Biology of the Cell, vol.16, issue.4, pp.1850-1858, 1819.
DOI : 10.1091/mbc.E04-08-0654

B. Barré, A. Vigneron, and O. Coqueret, The STAT3 Transcription Factor Is a Target for the Myc and Riboblastoma Proteins on the Cdc25A Promoter, Journal of Biological Chemistry, vol.280, issue.16, pp.15673-15681, 2005.
DOI : 10.1074/jbc.M413203200

B. Barre and N. Perkins, RETRACTED: The Skp2 Promoter Integrates Signaling through the NF-??B, p53, and Akt/GSK3?? Pathways to Regulate Autophagy and Apoptosis, Molecular Cell, vol.38, issue.4, pp.524-538, 2010.
DOI : 10.1016/j.molcel.2010.03.018

A. Vigneron, E. Gamelin, and O. Coqueret, The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition, Cancer Research, vol.68, issue.3, pp.815-825, 2008.
DOI : 10.1158/0008-5472.CAN-07-5115

A. Vigneron, J. Cherier, B. Barre, E. Gamelin, and O. Coqueret, The Cell Cycle Inhibitor p21waf1 Binds to the myc and cdc25A Promoters upon DNA Damage and Induces Transcriptional Repression, Journal of Biological Chemistry, vol.281, issue.46, pp.34742-34750, 2006.
DOI : 10.1074/jbc.M602492200

A. Vigneron, I. Roninson, E. Gamelin, and O. Coqueret, Src Inhibits Adriamycin-Induced Senescence and G2 Checkpoint Arrest by Blocking the Induction of p21waf1, Cancer Research, vol.65, issue.19, pp.8927-8935, 2005.
DOI : 10.1158/0008-5472.CAN-05-0461

. Courapied, http://www.molecular-cancer.com/content, Molecular Cancer Bromberg, J. J. Clin. Invest, vol.99205, issue.109, pp.205-1139, 2002.

H. Yu, J. , and R. , The STATs of cancer ??? new molecular targets come of age, Nature Reviews Cancer, vol.99, issue.2, pp.97-105, 2004.
DOI : 10.1038/nrc1275

D. E. Levy, L. , and C. K. , What does Stat3 do?, Journal of Clinical Investigation, vol.109, issue.9, pp.1143-1148, 2002.
DOI : 10.1172/JCI0215650

J. F. Bromberg, M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell et al., Stat3 as an Oncogene, Cell, vol.98, issue.3, pp.295-303, 1999.
DOI : 10.1016/S0092-8674(00)81959-5
URL : http://doi.org/10.1016/s0092-8674(00)81959-5

Z. Wen, Z. Zhong, D. , and J. E. Jr, Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation, Cell, vol.82, issue.2, pp.241-250, 1995.
DOI : 10.1016/0092-8674(95)90311-9

S. Giraud, F. Bienvenu, S. Avril, H. Gascan, D. M. Heery et al., Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a, Journal of Biological Chemistry, vol.277, issue.10, pp.8004-8011, 2002.
DOI : 10.1074/jbc.M111486200

S. Giraud, A. Hurlstone, S. Avril, C. , and O. , Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene, Oncogene, vol.23, issue.44, pp.7391-7398, 2004.
DOI : 10.1038/sj.onc.1207972

M. Paulson, S. Pisharody, L. Pan, S. Guadagno, A. L. Mui et al., Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent Sequences, Journal of Biological Chemistry, vol.274, issue.36, pp.25343-25349, 1999.
DOI : 10.1074/jbc.274.36.25343

K. Nakashima, M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune et al., Synergistic Signaling in Fetal Brain by STAT3-Smad1 Complex Bridged by p300, Science, vol.284, issue.5413, pp.479-482, 1999.
DOI : 10.1126/science.284.5413.479

H. R. Qin, H. J. Kim, J. Y. Kim, E. M. Hurt, G. J. Klarmann et al., Activation of Signal Transducer and Activator of Transcription 3 through a Phosphomimetic Serine 727 Promotes Prostate Tumorigenesis Independent of Tyrosine 705 Phosphorylation, Cancer Research, vol.68, issue.19, pp.7736-7741, 2008.
DOI : 10.1158/0008-5472.CAN-08-1125

J. Yang, X. Liao, M. K. Agarwal, L. Barnes, P. E. Auron et al., Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF??B, Genes & Development, vol.21, issue.11, pp.1396-1408, 2007.
DOI : 10.1101/gad.1553707

H. Lee, A. Herrmann, J. H. Deng, M. Kujawski, G. Niu et al., Persistently Activated Stat3 Maintains Constitutive NF-??B Activity in Tumors, Cancer Cell, vol.15, issue.4, pp.283-293, 2009.
DOI : 10.1016/j.ccr.2009.02.015

B. Barré, A. Vigneron, N. Perkins, I. B. Roninson, E. Gamelin et al., The STAT3 oncogene as a predictive marker of drug resistance, Trends in Molecular Medicine, vol.13, issue.1, pp.4-11, 2007.
DOI : 10.1016/j.molmed.2006.11.001

S. Sano, K. S. Chan, M. Kira, K. Kataoka, S. Takagi et al., Signal Transducer and Activator of Transcription 3 Is a Key Regulator of Keratinocyte Survival and Proliferation following UV Irradiation, Cancer Research, vol.65, issue.13, pp.5720-5729, 2005.
DOI : 10.1158/0008-5472.CAN-04-4359

Y. Shen, G. Devgan, J. E. Darnell, . Jr, and J. F. Bromberg, Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1, Proceedings of the National Academy of Sciences, vol.98, issue.4, pp.1543-1548, 2001.
DOI : 10.1073/pnas.98.4.1543

G. Niu, K. L. Wright, Y. Ma, G. M. Wright, M. Huang et al., Role of Stat3 in Regulating p53 Expression and Function, Molecular and Cellular Biology, vol.25, issue.17, pp.7432-7440, 2005.
DOI : 10.1128/MCB.25.17.7432-7440.2005

R. Catlett-falcone, T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki et al., Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells, Immunity, vol.10, issue.1, pp.105-115, 1999.
DOI : 10.1016/S1074-7613(00)80011-4

Z. Duan, R. Foster, D. A. Bell, J. Mahoney, K. Wolak et al., Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer, Clinical Cancer Research, vol.12, issue.17, pp.5055-5063, 2006.
DOI : 10.1158/1078-0432.CCR-06-0861

N. Diaz, S. Minton, C. Cox, T. Bowman, T. Gritsko et al., Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression, Clinical Cancer Research, vol.12, issue.1, pp.20-28, 2006.
DOI : 10.1158/1078-0432.CCR-04-1749

T. Gritsko, A. Williams, J. Turkson, S. Kaneko, T. Bowman et al., Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells, Clinical Cancer Research, vol.12, issue.1, pp.11-19, 2006.
DOI : 10.1158/1078-0432.CCR-04-1752

A. Vigneron, I. B. Roninson, E. Gamelin, C. , and O. , Src Inhibits Adriamycin-Induced Senescence and G2 Checkpoint Arrest by Blocking the Induction of p21waf1, Cancer Research, vol.65, issue.19, pp.8927-8935, 2005.
DOI : 10.1158/0008-5472.CAN-05-0461

A. Vigneron, E. Gamelin, C. , and O. , The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition, Cancer Research, vol.68, issue.3, pp.815-825, 2008.
DOI : 10.1158/0008-5472.CAN-07-5115

R. Dhavan and L. H. Tsai, A decade of CDK5, Nature Reviews Molecular Cell Biology, vol.4, issue.10, pp.749-759, 2001.
DOI : 10.1038/35096019

X. Gong, X. Tang, M. Wiedmann, X. Wang, J. Peng et al., Cdk5-Mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-Induced Apoptosis, Neuron, vol.38, issue.1, pp.33-46, 2003.
DOI : 10.1016/S0896-6273(03)00191-0

C. X. Wang, J. H. Song, D. K. Song, V. W. Yong, A. Shuaib et al., Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2, Cell Death and Differentiation, vol.13, issue.7, pp.1203-1212, 2006.
DOI : 10.1126/science.286.5448.2358

A. Vigneron, J. Cherier, B. Barré, E. Gamelin, C. et al., The Cell Cycle Inhibitor p21waf1 Binds to the myc and cdc25A Promoters upon DNA Damage and Induces Transcriptional Repression, Journal of Biological Chemistry, vol.281, issue.46, pp.34742-34750, 2006.
DOI : 10.1074/jbc.M602492200

H. V. Le, A. J. Minn, and J. Massagué, Cyclin-dependent Kinase Inhibitors Uncouple Cell Cycle Progression from Mitochondrial Apoptotic Functions in DNA-damaged Cancer Cells, Journal of Biological Chemistry, vol.280, issue.36, pp.32018-32025, 2005.
DOI : 10.1074/jbc.M504689200

B. Tian, Q. Yang, M. , and Z. , Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death, Nature Cell Biology, vol.20, issue.2, pp.211-218, 2009.
DOI : 10.1016/0092-8674(93)90500-P

K. Alexander, H. S. Yang, and P. W. Hinds, Cellular Senescence Requires CDK5 Repression of Rac1 Activity, Molecular and Cellular Biology, vol.24, issue.7, pp.2808-2819, 2004.
DOI : 10.1128/MCB.24.7.2808-2819.2004

H. S. Yang and P. W. Hinds, Increased Ezrin Expression and Activation by CDK5 Coincident with Acquisition of the Senescent Phenotype, Molecular Cell, vol.11, issue.5, pp.1163-1176, 2003.
DOI : 10.1016/S1097-2765(03)00135-7

A. K. Fu, W. Y. Fu, A. K. Ng, W. W. Chien, Y. P. Ng et al., Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity, Proceedings of the National Academy of Sciences, vol.101, issue.17, pp.6728-6733, 2004.
DOI : 10.1073/pnas.0307606100

K. Leslie, C. Lang, G. Devgan, J. Azare, M. Berishaj et al., Cyclin D1 Is Transcriptionally Regulated by and Required for Transformation by Activated Signal Transducer and Activator of Transcription 3, Cancer Research, vol.66, issue.5, pp.2544-2552, 2006.
DOI : 10.1158/0008-5472.CAN-05-2203

H. W. Lo, S. C. Hsu, M. Ali-seyed, M. Gunduz, W. Xia et al., Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway, Cancer Cell, vol.7, issue.6, pp.575-589, 2005.
DOI : 10.1016/j.ccr.2005.05.007

N. Kiuchi, K. Nakajima, M. Ichiba, T. Fukada, M. Narimatsu et al., Gene, The Journal of Experimental Medicine, vol.16, issue.1, pp.63-73, 1999.
DOI : 10.1016/S1074-7613(00)80445-8

B. Barré, S. Avril, C. , and O. , Opposite Regulation of Myc and p21waf1 Transcription by STAT3 Proteins, Journal of Biological Chemistry, vol.278, issue.5, pp.2990-2996, 2003.
DOI : 10.1074/jbc.M210422200

B. Barré, A. Vigneron, C. , and O. , The STAT3 Transcription Factor Is a Target for the Myc and Riboblastoma Proteins on the Cdc25A Promoter, Journal of Biological Chemistry, vol.280, issue.16, pp.15673-15681, 2005.
DOI : 10.1074/jbc.M413203200

N. Dendouga, H. Gao, D. Moechars, M. Janicot, J. Vialard et al., Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis, Molecular and Cellular Biology, vol.25, issue.17, pp.7569-7579, 2005.
DOI : 10.1128/MCB.25.17.7569-7579.2005

F. Osman, W. , and M. C. , Exploring the roles of Mus81-Eme1/Mms4 at perturbed replication forks, DNA Repair, vol.6, issue.7, pp.1004-1017, 2007.
DOI : 10.1016/j.dnarep.2007.02.019

Y. Pommier, C. Redon, V. A. Rao, J. A. Seiler, O. Sordet et al., Repair of and checkpoint response to topoisomerase I-mediated DNA damage, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.532, issue.1-2, pp.173-203, 2003.
DOI : 10.1016/j.mrfmmm.2003.08.016

M. Chatterjee-kishore, K. L. Wright, J. P. Ting, and G. R. Stark, How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene, The EMBO Journal, vol.136, issue.15, pp.4111-4122, 2000.
DOI : 10.1093/emboj/19.15.4111

P. A. Townsend, M. S. Cragg, S. M. Davidson, J. Mccormick, S. Barry et al., STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage, Journal of Cell Science, vol.118, issue.8, pp.1629-1639, 2005.
DOI : 10.1242/jcs.01728

M. Thomas, C. E. Finnegan, K. M. Rogers, J. W. Purcell, A. Trimble et al., STAT1: A Modulator of Chemotherapy-induced Apoptosis, Cancer Research, vol.64, issue.22, pp.8357-8364, 2004.
DOI : 10.1158/0008-5472.CAN-04-1864

A. Slupianek, C. Schmutte, G. Tombline, M. Nieborowska-skorska, G. Hoser et al., BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance, Molecular Cell, vol.8, issue.4, pp.795-806, 2001.
DOI : 10.1016/S1097-2765(01)00357-4

A. Slupianek, G. Hoser, I. Majsterek, A. Bronisz, M. Malecki et al., Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G2/M Phase, and Protection from Apoptosis, Molecular and Cellular Biology, vol.22, issue.12, pp.4189-4201, 2002.
DOI : 10.1128/MCB.22.12.4189-4201.2002

B. J. Shields, C. Hauser, P. E. Bukczynska, N. W. Court, and T. Tiganis, DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression, Cancer Cell, vol.14, issue.2, pp.166-179, 2008.
DOI : 10.1016/j.ccr.2008.06.003

O. Vafa, M. Wade, S. Kern, M. Beeche, T. K. Pandita et al., c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function, Molecular Cell, vol.9, issue.5, pp.1031-1044, 2002.
DOI : 10.1016/S1097-2765(02)00520-8
URL : http://doi.org/10.1016/s1097-2765(02)00520-8

K. J. Campbell, J. M. Witty, S. Rocha, and N. D. Perkins, Cisplatin Mimics ARF Tumor Suppressor Regulation of RelA (p65) Nuclear Factor-??B Transactivation, Cancer Research, vol.66, issue.2, pp.929-935, 2006.
DOI : 10.1158/0008-5472.CAN-05-2234

H. Lin, M. C. Chen, C. Y. Chiu, Y. M. Song, L. et al., Cdk5 Regulates STAT3 Activation and Cell Proliferation in Medullary Thyroid Carcinoma Cells, Journal of Biological Chemistry, vol.282, issue.5, pp.2776-2784, 2007.
DOI : 10.1074/jbc.M607234200

V. A. Flørenes, C. Lu, N. Bhattacharya, J. Rak, C. Sheehan et al., Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma, Oncogene, vol.18, issue.4, pp.1023-1032, 1999.
DOI : 10.1038/sj.onc.1202382

F. Bienvenu, B. Barre, S. Giraud, S. Avril, C. et al., Transcriptional Regulation by a DNA-associated Form of Cyclin D1, Molecular Biology of the Cell, vol.16, issue.4, pp.1850-1858, 2005.
DOI : 10.1091/mbc.E04-08-0654

B. W. Henderson, C. Daroqui, E. Tracy, L. A. Vaughan, G. M. Loewen et al., Cross-Linking of Signal Transducer and Activator of Transcription 3--A Molecular Marker for the Photodynamic Reaction in Cells and Tumors, Clinical Cancer Research, vol.13, issue.11, pp.3156-3163, 2007.
DOI : 10.1158/1078-0432.CCR-06-2950

M. Benekli, H. Baumann, and M. Wetzler, Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias, Journal of Clinical Oncology, vol.27, issue.26, pp.4422-4432, 2009.
DOI : 10.1200/JCO.2008.21.3264